AXEL BOLTE

Corporate Board Profile

Tech Score: 0/100

PTC THERAPEUTICS, INC.

Filing Date	Source Excerpt
2014-04-28	Axel Bolte Audit Committee Age 59 Mr. Bolte has served as a member of our Board since December 2003. Since September 2006, Mr. Bolte has served as a consultant to Vulcan Capital, the private investment group of Vulcan Inc., and Mr. Bolte served as Managing Director of biotechnology venture investments at Vulcan Capital from September 2003 to September 2006. From July 1996 to July 2002, Mr. Bolte served as Chief Executive Officer at Oxford GlycoSciences, a biotechnology company. Prior to joining Oxford GlycoSciences, Mr. Bolte was President and Chief Operating Officer at Immunex Corporation (now Amgen), a biopharmaceutical company. Mr. Bolte currently serves as Chief Executive Officer and a director of BEAT BioTherapeutics Corporation, a gene therapy company. Mr. Bolte received a B.A. and an M.B.A from the University of Washington School of Business. We believe that Mr. Bolte is qualified to serve on our Board because of his many years of service as one of our directors, his extensive experience in the life sciences industry and his service on the boards of directors of other life sciences companies.

Filing Date

Source Excerpt

2014-04-28

Axel Bolte Audit Committee Age 59 Mr. Bolte has served as a member of our Board since December 2003. Since September 2006, Mr. Bolte has served as a consultant to Vulcan Capital, the private investment group of Vulcan Inc., and Mr. Bolte served as Managing Director of biotechnology venture investments at Vulcan Capital from September 2003 to September 2006. From July 1996 to July 2002, Mr. Bolte served as Chief Executive Officer at Oxford GlycoSciences, a biotechnology company. Prior to joining Oxford GlycoSciences, Mr. Bolte was President and Chief Operating Officer at Immunex Corporation (now Amgen), a biopharmaceutical company. Mr. Bolte currently serves as Chief Executive Officer and a director of BEAT BioTherapeutics Corporation, a gene therapy company. Mr. Bolte received a B.A. and an M.B.A from the University of Washington School of Business. We believe that Mr. Bolte is qualified to serve on our Board because of his many years of service as one of our directors, his extensive experience in the life sciences industry and his service on the boards of directors of other life sciences companies.

Data sourced from SEC filings. Last updated: 2026-03-14